17th Multidisciplinary Management of Cancerscare. The faculty at the Stanford Cancer Institute, UC...
Transcript of 17th Multidisciplinary Management of Cancerscare. The faculty at the Stanford Cancer Institute, UC...
17th Multidisciplinary Management of Cancers:A CASE-BASED APPROACHSPONSORED BY the Association of Northern California Oncologists, Stanford Cancer Institute, UC Davis Comprehensive Cancer Center, and UCSF Helen Diller Family Comprehensive Cancer Center.
2017 TUMOR BOARD CASES AND PANELS
March 17-19, 2017Silverado Resort & SpaNapa, California
• Breast Cancer• Developmental Therapeutics• End of Life Care• Gastrointestinal Cancers
• Genitourinary Cancers• Gynecologic Cancers• Head and Neck Cancers• Hematologic Malignancies
• Lymphoma• Sarcoma• Thoracic Cancer
CONFERENCE INFORMATION
Multidisciplinary Management of Cancers:A Case-based Approach
CONFERENCE DESCRIPTIONThis conference will present the most current information on multidisciplinary approaches in clinical oncology and will consist of tumor board cases on breast, gastrointestinal, genitourinary, gynecologic, head and neck, hematologic malignancies, lymphoma, sarcoma, and thoracic cancers as well as developmental therapeutics and end-of-life care. The tumor board cases will be presented by faculty, with discussion by a panel of surgical, radiation and medical oncologists from Stanford, UC Davis, UC San Francisco, and the practice community.
TARGET AUDIENCEThis course is designed for physicians specializing in medical, surgical, and radiation oncology as well as nurses, pharmacists, and other allied health professionals who work with cancer patients.
STATEMENT OF EDUCATIONAL NEED Because the standard of care in oncology changes rapidly with new discoveries, there is a need for frequent updates of practical relevance for the practicing oncologist. This conference will emphasize standard of care issues for various cancers including diagnostic and therapeutic decision-making and optimal approaches to supportive and palliative care. The faculty at the Stanford Cancer Institute, UC Davis Comprehensive Cancer Center, and UCSF Helen Diller Family Comprehensive Cancer Center put a premium on optimal multidisciplinary modeling treatment and education of the practicing oncologist to ensure they are up to date. The American Society for Clinical Oncology recommends this multidisciplinary meeting format. This symposium and its faculty specifically address the clinical guidelines set forth by the National Comprehensive Cancer Network.
LEARNING OBJECTIVESAt the conclusion of this activity, participants will be able to:1. Develop multidisciplinary treatment strategies based on
national clinical practice guidelines in oncology in order to improve quality of care for cancer patients.
2. Counsel patients on end-of-life care. 3. Discuss relevant clinical trials with cancer patients and
refer appropriately.
CONFERENCE FORMATThe format of the conference is oriented around tumor board
cases. We will use an interactive group response system with an electronic keypad for each participant during the case discussions. We encourage you to submit cases for discussion.
CALL FOR CASE SUBMISSIONSRegistrants are encouraged to submit a case or cases for the panels to discuss. Deadline for case submissions is Friday, December 30, 2016. The organizing committee and panel chairs will select cases. Please visit the course website for the case submission form: www.multicancers.org.
ACCREDITATION AND CREDIT DESIGNATIONPhysicians. The University of California, San Francisco, Office of Continuing Medical Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The University of California, San Francisco, Office of Continuing Medical Education designates this live activity for a maximum of 16 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurses. The California Board of Registered Nursing recognizes that Continuing Medical Education (CME) is acceptable for meeting RN continuing education requirements, as long as the course is certified for AMA PRA Category 1 Credits™ (rn.ca.gov). Nurses will receive a Certificate of Attendance following this activity that may be used for license renewal.
Physician Assistants. AAPA accepts category 1 credit from AOACCME, Prescribed credit from AMA category 1 credit forthe PRA for organizations accredited by the ACCME.
FACULTY DISCLOSURE The University of California, San Francisco, Office of Continuing Medical Education adheres to ACCME Essential Areas, Standards, and Policies regarding industry support of continuing medical education. Disclosure of faculty and commercial relationships will be made prior to the activity.
PLANNING COMMITTEEA. Dimitrios Colevas, MD (Conference Co-Director)David Gandara, MD (Conference Co-Director)Margaret Tempero, MD (Conference Co-Director) Courtney Flookes and Jose Luis Gonzalez (Conference Planners)
Tell a colleague! To register online go to: www.multicancers.org 2
MESSAGE SCHEDULEfrom the Co-Directors
Dear Colleagues,
It is a pleasure for us to invite you to the 17th
Multidisciplinary Management of Cancers meeting to
be held March 17-19, 2017. The 2017 program represents
a collaborative effort of expert clinicians from the
Stanford Cancer Institute, University of California,
Davis, University of California, San Francisco, and the
Association of Northern California Oncologists.
Based on the recurrent enthusiasm for a case oriented
approach we once again will be tackling some of
the toughest cases, heavily relying upon audience
participation and feedback. Community oncologists
will be represented on the panels as well. With that
in mind, we remind you that we look forward to your
submission of real cases to discuss. Using our online
case submission form, please submit cases for us by the
end of December 2016. We will select cases from among
those submitted for presentation.
Our primary goal of this meeting, as always, is to
provide learners with the latest developments in the
multidisciplinary management of cancers.
Space is limited so register early. We look forward to
your participation at this meeting.
Sincerely,
FRIDAY, MARCH 17, 20177:30–8:30 Registration and Continental Breakfast
8:30–8:45 Welcome and Opening Remarks
8:45–10:45 Breast Cancer Tumor Board Cases (2 hrs) Helen K. Chew, MD – CHAIR
Professor of Medicine, The Joe Sullivan Hematology and Oncology Program Director, UC Davis
Richard J. Bold, MD, UC Davis
Kathleen Horst, MD, Stanford
Leslie Oesterich, MD, UC Davis
Hope S. Rugo, MD, UC San Francisco
George W. Sledge, Jr., MD, Stanford
Melinda Telli, MD, Stanford
Amanda Wheeler, MD, Stanford
10:45–11:00 Break
11:00–12:00 Head and Neck Cancers Tumor Board Cases (1 hr)
Sue Yom, MD, PhD – CHAIR Associate Professor, Department of Radiation Oncology, UC San Francisco
Alain Algazi, MD, UC San Francisco
Beth M. Beadle, MD, PhD, Stanford
Christopher Chapman, MD, UC San Francisco
A. Dimitrios Colevas, MD, Stanford
Patrick Ha, MD, UC San Francisco
Chris Holsinger, MD, Stanford
Jed Katzel, MD, The Permanente Medical Group
Shyam Rao, MD, PhD, UC Davis
Jonathan Riess, MD, MS, UC Davis
12:00–1:00 Lunch
1:00–3:00 Hematologic Malignancies Tumor Board Cases (2 hrs)
Jason Gotlib, MD, MS – CHAIRProfessor of Medicine, Stanford
Mehrdad Abedi, MD, UC Davis
Lloyd Damon, MD, UC San Francisco
Brian A. Jonas, MD, PhD, UC Davis
Greg Kaufman, MD, Stanford
Michaela Liedtke, MD, Stanford
Bruno Medeiros, MD, Stanford
Neil Shah, MD, PhD, UC San Francisco
Ann Von Gehr, MD, The Permanente Medical Group
3:00–3:15 Break
3:15–5:15 Thoracic Cancer Tumor Board Cases (2 hrs)
Joel Neal, MD – CHAIR Assistant Professor of Medicine (Oncology), Stanford
Deepti Behl, MD, Sutter Sacramento
Colin Blakely, MD, PhD, UC San Francisco
Megan Daly, MD, UC Davis
Elizabeth David, MD, UC Davis
David Gandara, MD, UC Davis
Matthew A. Gubens, MD, MS, UC San Francisco
Billy W. Loo, Jr., MD, PhD, Stanford
Michael Mancuso, MD, Stanford
Joseph B. Shrager, MD, Stanford
3
A. Dimitrios Colevas, MD Conference Co-Director Professor of Medicine (Oncology)
and by courtesy, Otolaryngology, Head and Neck Surgery,
Stanford University School of Medicine
David Gandara, MD Conference Co-Director Thoracic Oncology Program, UC Davis Health System;
Professor, UC Davis Medical School;
Senior Advisor to Director, UC Davis Comprehensive
Cancer Center
Margaret Tempero, MD Conference Co-Director Director, UCSF Pancreas Center;
Leader, Pancreas Cancer Program,
Professor of Medicine, Division of Hematology and
Oncology, UC San Francisco
4
SCHEDULE
FRIDAY, MARCH 17, 2017 – CONTINUED5:15 Adjourn
6:00–7:30 Welcome Reception
SATURDAY, MARCH 18, 20177:00–7:45 Registration, Continental Breakfast, & Displays
7:45–8:00 Welcome and Opening Remarks
8:00–9:30 Lymphoma Tumor Board Cases (1.5 hrs)
Joseph Tuscano, MD – CHAIR Professor of Medicine, UC Davis
Charalambos (Babis) Andreadis, MD, UC San Francisco
Richard Hoppe, MD, Stanford
Lawrence Kaplan, MD, UC San Francisco
Kasra Karamlou, MD, Diablo Valley Hematology Oncology
Rajeev Krishnan, MD, UC Davis
Ronald Levy, MD, Stanford
9:30–9:45 Break
9:45–11:15 End of Life Care Tumor Board Cases (1.5 hrs)
Kavitha Ramchandran, MD– CHAIR Clinical Assistant Professor; Medical Director, Palliative Medicine and PathWell, Stanford
John Hausdorff, MD, Pacific Cancer Care
David Magnus, PhD, Stanford
Daniel Mirda, MD, Annadel Medical Group
Michael Rabow, MD, UC San Francisco
Piyush Srivastava, MD, The Permanente Medical Group
Diane Tseng, MD, Stanford
11:15–12:15 Lunch
12:15–1:45 Genitourinary Cancers Tumor Board Cases (1.5 hrs)
Charles Ryan, MD – CHAIR Professor of Clinical Medicine and Urology; Thomas Perkins Distinguished Professor in Cancer Research, UC San Francisco
Archana Anantharaman, MD, UC San Francisco
Mark K. Buyyounouski, MD, MS, Stanford
Andrea Harzstark, MD, The Permanente Medical Group
Primo N. Lara, Jr., MD, UC Davis
Chong-Xian Pan, MD, PhD, UC Davis
Mack Roach III, MD, UC San Francisco
Eila Skinner, MD, Stanford
Eric Small, MD, UC San Francisco
Sandy Srinivas, MD, Stanford
1:45–2:00 Break
2:00–3:30 Gynecologic Cancers Tumor Board Cases (1.5 hrs)
Oliver Dorigo, MD, PhD – CHAIR Director and Associate Professor, Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Stanford
Lee-may Chen, MD, UC San Francisco
Gary Leiserowitz, MD, MS, UC Davis
Jyoti Mayadev, MD, UC Davis
Jennifer Leah McNally MD, Stanford
Bethan Powell, MD, The Permanente Medical Group
Karen Smith-McCune, MD, PhD, UC San Francisco
Betty Suh-Burgmann, MD, The Permanente
Medical Group
Stefanie Ueda, MD, UC San Francisco
3:30 Adjourn
SUNDAY, MARCH 19, 20177:00–7:45 Registration, Continental Breakfast, & Displays
7:45–8:00 Welcome and Opening Remarks
8:00–9:30 Gastrointestinal Cancers Tumor Board Cases (1.5 hrs) Alan Venook, MD – CHAIR
The Madden Family Distinguished Professor of Medical Oncology and Translational Research, UC San Francisco
Emily Bergsland, MD, UC San Francisco
Carlos Corvera, MD, UC San Francisco
Mary Feng, MD, UC San Francisco
George A. Fisher, MD, PhD, Stanford
Edward Kim, MD, PhD, UC Davis
Zach Koontz, MD, Pacific Cancer Care
Pamela Kunz, MD, Stanford
Yan Li, MD, The Permanente Medical Group
Margaret Tempero, MD, UC San Francisco
Carling Ursem, MD, UC San Francisco
Brendan C. Visser, MD, Stanford
9:30–9:45 Break
9:45–11:15 Sarcoma Tumor Board Cases (1.5 hrs)Robert Canter, MD – CHAIR Associate Professor of Surgery, Division of Surgical Oncology, UC Davis
Raffi Avedian, MD, Stanford
Kristen Ganjoo, MD, Stanford
Thierry Jahan, MD, UC San Francisco
Lynn Million, MD, Stanford
Ross Okimoto, MD, UC San Francisco
Ming-Gui Pan, MD, The Permanente Medical Group
Rosanna Wustrack, MD, UC San Francisco
11:15–11:30 Break
11:30–1:00 Developmental Therapeutics (1.5 hrs)Pamela Munster, MD – CHAIR Professor of Medicine; Director, Early Phase Clinical Trials; Co-Director, Center for BRCA Research, UC San Francisco
Rahul Aggarwal, MD, UC San Francisco
Mallika Dhawan, MD, UC San Francisco
Karen Kelly, MD, UC Davis
Shivaani Kummar, MD, Stanford
Tianhong (Tina) Li, MD, PhD, UC Davis
Arta Monjazeb, MD, PhD, UC Davis
Branimir I. (Brandy) Sikic, MD, Stanford
1:00 Adjourn
Panelists have been invited; program subject to change. Opportunities for Q&A will be provided during each panel.
5
REGISTER
REGISTRATIONRegistration includes course materials, continental breakfast each day, lunch on Friday and Saturday, and a hosted welcome reception on Friday evening.
ANCO MD Members: $475
Other MD, PhD, PharmD: $500 Early Bird – Registration before 2/1/17
$550 Registration 2/1/17–2/28/17
$600 Late Registration 3/1/17–3/10/17
Nurses/Allied Health: $350 Early Bird – Registration before 2/1/17
$400 Registration 2/1/17–2/28/17
$450 Late Registration 3/1/17–3/10/17
Trainees and students: $100
Industry Representatives: $750
To register, please go online to www.multicancers.org
ACCEPTED METHODS OF PAYMENTCredit Card (Visa, Mastercard, or American Express) – Register online at www.multicancers.org. If you prefer to pay by phone or check, please contact the University of California, San Francisco, Office of Continuing Medical Education at 415-476-5808 for assistance (note that your registration is not confirmed until payment is received).
Online registration closes at end of business day on 3/10/17. Registration will open onsite the day of the conference if space is available. A $75 onsite registration fee will be added to all onsite registrations. Course materials are not guaranteed for onsite registrants.
CANCELLATION POLICYAll cancellations must be made in writing and sent to University of California, San Francisco, Office of Continuing Medical Education, 3333 California Street, Suite 450, San Francisco, CA 94118, or [email protected]. Registration fee, less a $50 administrative charge is refundable if written cancellation is received prior to March 3, 2017. No refunds will be given for cancellations received after this date or for conference non-attendance. We reserve the right to cancel or postpone any activity if necessary. In such case, full refund of registration fee will be given. We are not responsible for other costs incurred such as non-refundable airline tickets or hotel penalties.
CONTACT INFORMATIONFor questions concerning registration or meeting logistics, please contact:
UCSF Office of CME3333 California Street, Suite 450San Francisco, CA 94118415-476-5808 • [email protected]
UCSF Office of CME is fully ADA compliant. If you have needs that require special accommodations, including dietary concerns, please contact [email protected] before March 3, 2017.
0569University of California,San FranciscoOffice of ContinuingMedical EducationUCSF Box 0742San Francisco, CA94143-0742
Conference Information continued...
CONFERENCE LOCATIONSilverado Resort & Spa
1600 Atlas Peak Road • Napa, California 94558 tel: 707.257.0200
For driving directions and maps, please visit silveradoresort.com/directions
SILVERADO RESORT CONTACT INFORMATION
Silverado Reservations: 1.800.532.0500
Spa Reservations: (707)-257-5555 • Golf Reservations: (707) 257-5460
ACCOMMODATIONSA block of rooms has been reserved at a reduced rate at the Silverado Resort and Spa. Resort guestrooms are available at the rate of $175; junior suites are available at the rate of $215; and, one-bedroom suites are available at the rate of $250 plus tax and resort fees per night (single or double occupancy).
Room reservations should be made directly with the Silverado Resort and Spa and as early as possible. The ‘Multidisciplinary Management of Cancers’ room block rates will only be available until Tuesday, February 14, 2017. After this date, reservations will be accepted on a space available basis and at regular resort rates.
Please go to https://resweb.passkey.com/go/Multicancers to make your hotel reservations or call 1.800.532.0500.
VISITING NAPA & RESTAURANTSThe Napa Valley is world renown as being a premier destination to visit for wineries, golf, arts and culture as well as its famous culinary scene. To discover things to do and restaurants to visit in the Valley, please go to www.visitnapavalley.com.